Objectives-To determine whether (3 carotene is therapeutically equivalent to retinyl palmitate in the formulation currently recommended by the World Health Organisation.
Introduction
Up to 40 million children worldwide are estimated to suffer from vitamin A deficiency, which is associated with increased morbidity and mortality and leads to blindness.`These observations prompted the World Health Organisation to recommend appropriate prevention strategies-' based on oral administration of a large dose of vitamin A in the form of retinyl esters, particularly retinyl palmitate, to combat vitamin A deficiency and xerophthalmia. A dose of 200000 IU retinyl palmitate to children over 1 year old is most widely used and has generally been regarded as a safe and potentially effective intervention according to biochemical,6 cytological,7 and clinical indicators. 8 Prevention strategies differ only in the frequency of oral administration: every 3-6 months for periodic administration; immediately on diagnosis, the following day, and four weeks later for treating xerophthalmia.
In developing countries, animal products that provide retinyl esters are too expensive for most families to consume regularly in large quantities. Vegetables and fruit, which are cheap and good sources of vitamin A in the form of ( carotene, are grown almost everywhere but are not consumed in adequate amounts.' (3 Carotene is also considered to be virtually non-toxic (unlike retinyl esters, for which toxicity has been reported) and its metabolism differs from that of retinyl palmitate.' II It has recently been suggested that vitamin A deficiency can be treated with a rich natural source of carotenoids.12 In a preliminary study, Brazilian children were fed buriti palm fruit as a supplement in their normal diet. This fruit provides about 40% of a child's daily vitamin A requirement.'3 After 20 days there was reversion of the clinical and subclinical signs of vitamin A deficiency in the study group.'2 Small daily doses of ( carotene therefore show promise as a means of alleviating vitamin A deficiency. Since ( carotene is the principal source of vitamin A in developing countries and is non-toxic, we compared retinyl palmitate and (3 carotene for treatment of vitamin A deficiency.
We conducted a randomised blind equivalence trial among 510 vitamin A deficient Senegalese children to test the equivalence'"" between the effects of a large oral dose of either retinyl palminate or (3 carotene in correcting vitamin A deficiency as defined by abnormal results on eye cytology."819 As no published reports describe the use of a single large dose of ( carotene, the objective of our study was to determine whether ( carotene was therapeutically equivalent to retinyl palmitate at the present formulation (200 000 IU) recommended by the World Health Organisation.'
Subjects and methods
SUBJECTS
The study was conducted between February and April 1991 among Senegalese children aged 2-15 years from 30 rural villages of the community of Malicounda in the Thies region. Previous surveys have been carried out in this community where vitamin A deficiency is present among preschool and also school age children.20 Children were divided into two age groups according to the World Health Organisation criteria for assessing vitamin A deficiency.' All children from these randomly selected villages20 were recorded by trained community workers and were enrolled in the survey, giving a total number of 1488 subjects. Civil status and ophthalmic and anthropometric data were recorded for each child.
To be eligible for the equivalence trial, children had to be resident in the Malicounda rural community, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] 
massive oral dose of retinyl palmitate or P carotene if they were equivalent (5= 100%); and n is the required number of children for each group (n= 310). According to the formula, a sample of 620 vitamin A deficient children (two groups of 310) was necessary for this trial.
Statistical tests
We used the normal approximation of the distribu- We also investigated the percentage of children who reverted to normality in the two treatment groups for age, sex, nutritional status, and ocular infection, which are prognostic factors for the condition studied. Classic tests of interaction were used to assess whether the factors affected the observed difference in treatment.29
Results
A total of 620 vitamin A deficient children were required for this trial. Due to practical conditions of work in the fields (the approach of the mango season), we stopped enrolment at 510 vitamin A deficient children from a total of 1488 children examined. This sample size of 510 resulted in a loss of power of 7%, according to Makuch and Simon's formula where za= 1-65 for ox= 5% and z3= 0-61 for a power of 73%.f7
BASELINE CHARACTERISTICS
The 510 vitamin A deficient children were randomly allocated to either the retinyl palmitate group (n= 256) or the E carotene group (n= 254). The two groups were nearly identical in terms of the potential confounding variables of sex, age, nutritional status, and ocular infections at baseline examination (table I) . Approximately a third of the vitamin A deficient children were classified by anthropometry as undernourished (< 2 SD below the median). Stunting affected a somewhat larger proportion of the children than wasting, indicating that prolonged malnutrition was more common than acute malnutrition. Roughly half of the vitamin A deficient children also suffered from After seven weeks, 488 children were available for re-examination (95% in the retinyl palmitate group and 97% in the f carotene group). Seventeen subjects did not present at the second examination and were thus lost to follow up. Impression cytology with transfer could not be performed on five further subjects at week 7 because of the child's non-acceptance.
The vitamin A status of both supplemented groups had improved. In the retinyl palmitate group 51-2% of children were normal after seven weeks and 50% were normal in the P carotene group, a difference of 1-2% (95% confidence interval 0-8% to 1-6%).
According to the equivalence testing procedure previously described, z= -1-94 and one tailed p=0-03. The null hypothesis of non-equivalence was thus rejected. Therefore 3 validity data of impression cytology with transfer calculated according to a serum retinol cut off at 0 35 pumolIl, and that the test was even more sensitive when only the sample of children with eye infections was considered.19 After seven weeks, there was no evidence of difference between the treatments in children with or without eye infections, suggesting that (3 carotene has the same therapeutic effect as retinyl palmitate in children with trachoma or conjunctivitis. Our findings are consistent with the preliminary survey conducted in Brazil in which 44 vitamin A deficient children were given buriti palm fruit supplements and showed replenishment of their hepatic reserves and partial or complete regression of clinical signs."2 Several studies have also reported that Indonesian or African children with xerophthalmia consume foods rich in provitamin A less frequently than do clinically normal children.3"32
As both treatments had similar effects the 488 children could be considered as a whole. Seven weeks after vitamin A supplementation only 51% had normal findings on cytology, a figure similar to the 45% in a previous study.28 These results contrast with studies conducted in areas of endemic vitamin A deficiency in India33 34 and in Indonesia,35 where almost all children with abnormal cytology reverted to normal after retinyl palmitate treatment. The disparity with the African and Asian studies may be due to protein malnutrition. Vitamin A circulates on demand from the hepatic reserves to peripheral tissues by means of specific carrier proteins: retinol binding protein and transthyretin. 36 The two proteins are synthesised by the liver and are sensitive to acute variations in proteinenergy status. If the diet is low in protein, vitamin A is not released from the liver and its transport is impaired owing to insufficient hepatic biosynthesis of the retinol binding protein and the transthyretin. Therefore, the satisfactory supply of vitamin A to peripheral targets (such as the eye) depends on the hepatic synthesis particularly of retinol binding protein and also transthyretin. This hepatic synthesis is inadequate in populations with mainly cereal diets poor in essential amino acids,3' as in these villages of Senegal, where little fish and less meat are eaten. The transthyretin is widely implicated in the inflammatory reaction and its serum levels may therefore be considered as a nutritional index only in the absence of inflammation.38 In our experience, however, the prognostic value of the transthyretin was not modified by the synthesis of defence factors involved in infectious diseases.39 Mean serum retinol binding protein and transthyretin concentrations did not increase after vitamin A treatment in children in Senegal, who have only cereal diets.28
Our study was conducted in a Senegalese area where vitamin A deficiency is common.20 Food rich in vitamin A-meat, dairy products, and fish-is rarely consumed, and most dietary vitamin A is derived from vegetables rich in carotenoids. The main source is mango, which is available only during the harvest season (May to September) and is the most popular fruit for many Senegalese.' The cytological changes (reversion to normality) assessed in this trial can thus be attributed only to massive oral doses of retinyl palmitate or ( carotene. Other natural vitamin A supplies or environmental factors were not confounding factors since the study was conducted before the mango season and vitamin A deficient children were randomly ascribed to either the retinyl palmitate or (3 carotene treatment groups.
We applied stringent criteria for success, which has not always been the case in other studies.'2 The randomised blind procedure and the complete compliance ensured by the medical team giving the vitamin A capsules ought to have reduced inaccuracy. Children were selected and followed up on the same cytological criterion for vitamin A deficiency as impression cytology with transfer is an easy method to perform in the field in comparison to blood sampling and analyses and is also reproducible (intraobserver variation is low and results are independent of the site of sampling the conjunctival cells of the eye).4' Because of the time required for screening 1488 children in the field with impression cytology with transfer (this has not previously been done with such large numbers) and the approach of mango season, we stopped our enrolment when a sample size of 510 vitamin A deficient children was obtained. This sample size led to a loss of power of 7% compared with the optimal sample of 620 but did not change the outcome of this survey, although we decided to run a small risk of 5% of rejecting the null hypothesis of non-equivalence when it was actually true. Only 4% of subjects were lost to follow up; they were almost equally distributed between the two treatment groups and would not therefore be expected to influence the outcome.
VITAMIN A AND PUBLIC HEALTH Since ( carotene supplementation had a therapeutically similar effect to retinyl palmitate for vitamin A deficient children, the study has important public health implications in the struggle against vitamin A deficiency. (3 Carotene has advantages over retinyl palmitate in terms of toxicity, its availability in developing countries, and cost effectiveness.
Firstly, several studies have reported that large doses of retinyl palmitate can induce signs of raised intracranial tension such as bulging fontanelle, restlessness, fever, and vomiting in children and potential teratogenicity in pregnant women." There has been no report of toxic symptoms resulting from excessive intake of carotene. The only known consequence is yellow pigmentation of the skin. Therefore ( carotene could be given to pregnant and lactating women to increase their body stores and the vitamin A content of milk since ( carotene is safer than retinyl palmitate and has no risk of teratogenicity. However, no side effects of retinyl palmitate were reported during our trial.
Secondly, ( carotene is widely found in coloured fruits and vegetables, which are indeed the principal source of vitamin A. These products are widely available and less expensive than animal products in developing countries. Nutritional education and appropriate preservation technologies leading to increased consumption of carotenoids should be financially more advantageous than the consumption of retinyl esters, which are derived from animal products. Considering capsule supplementation, it is presently not possible to compare the cost of the two treatments because a capsule form of (3 carotene has never been used to treat vitamin A deficiency.'2 The price would depend on the quantity of capsules produced. In our study the cost per treatment was US$0 78 for 1 200 000 IU of ( carotene and US$0 02 for 200 000 IU of retinyl palmitate.
The objective of our study was to determine whether single oral doses of ( carotene were therapeutically equivalent of retinyl palmitate. ( Clinical implications * Vitamin A deficiency, resulting in blindness, is a public health problem in developing countries * Prevention strategy is generally based on oral administration of a large dose of retinyl palmitate associated with risk of toxicity * A randomised blind equivalence trial conducted on 510 vitamin A deficient Senegalese children shows that 1B carotene is equivalent to retinyl palmitate * d Carotene, virtually non-toxic, could be used as substitute for retinyl palmitate in large dose capsule * The challenge is to improve dietary intake through vegetables which are widely available and the major source of carotenoids Organisation for retinyl palmitate5 is thus a good method for vitamin A prophylaxis. Obviously, the best approach would be to encourage increased dietary intake of vitamin A through the consumption of carotenoid rich, coloured fruit and vegetables, which are the major sources of vitamin A in developing countries. d Carotene is non-toxic and as effective as retinyl palmitate. Additionally, there is growing evidence that 3 carotene enhances the immune response. 43 Consequently, d carotene could be used as a substitute for retinyl palmitate to address the problems of not only blindness but also mortality and morbidity, although there are as yet no surveys to assess impact on survival. Many foods rich in d carotene available in developing countries are not offered to children. The challenge now is to improve the dietary intake of vitamin A in programmes that are effective and sustainable at the community level to struggle against blindness and to improve child survival. 
